1. Role of CD4+ T helper cells (Th1, Th2 and Th17 cells) in Recurrent pregnancy loss 2. Role of Nature Killer and Innate lymphoid cells in Recurrent pregnancy loss 3. Role of T Regulatory in Recurrent pregnancy loss 4. Role of CD8+ Cytotoxic T cells in Recurrent pregnancy loss 5. Role of B cells, macrophages and dendritic cells in Recurrent pregnancy loss 6. Clinical outcome of Low molecular weight heparin and aspirin therapy in Recurrent pregnancy loss patients 7. Clinical outcome of Intravenous immunoglobulin (IVIg) therapy in Recurrent pregnancy loss patients 8.

Vitamin D3 therapy and clinical outcome in Recurrent pregnancy loss patients 9. Efficacy of Intralipid infusion therapy in the treatment of Recurrent pregnancy loss patients 10. Therapeutic potential of Cyclosporine A in Recurrent pregnancy loss 11. Progesterone therapy and clinical outcome in Recurrent pregnancy loss patients 12. Granulocyte-Colony Stimulating Factor (G-CSF) therapy in Recurrent pregnancy loss patients 13. Lymphocyte immunotherapy (LIT) and clinical outcome in Recurrent pregnancy loss patients 14. TNFa inhibition and treatment of Recurrent pregnancy loss 15. Genetic counselling and clinical pregnancy outcome 16.

Importance of evidence-based medical treatments for Recurrent pregnancy loss 17. Evidence-based new developments in reproductive immunogenetics and future perspectives.